LY6K promotes glioblastoma tumorigenicity via CAV-1-mediated ERK1/2 signaling enhancement (vol 22, pg 1315, 2020)

被引：0
|
作者：
Sastry, Namratha G.
Wan, Xuechao
Huang, Tianzhi
Alvarez, Angel A.
Pangeni, Rajendra P.
Song, Xiao
James, Charles David
Horbinski, Craig M.
Brennan, Cameron W.
Nakano, Ichiro
Hu, Bo
Cheng, Shi-Yuan
机构：
来源：
NEURO-ONCOLOGY | 2024年 / 26卷 / 10期
关键词：
D O I：
10.1093/neuonc/noae151
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1947 / 1947
页数：1
相关论文
共 50 条
  • [1] LY6K promotes glioblastoma tumorigenicity via CAV-1 mediated ERK1/2 signaling enhancement
    Sastry, Namratha G.
    Wan, Xuechao
    Huang, Tianzhi
    Alvarez, Angel A.
    Pangeni, Rajendra P.
    Song, Xiao
    James, Charles David
    Horbinski, Craig M.
    Brennan, Cameron W.
    Nakano, Ichiro
    Hu, Bo
    Cheng, Shi-Yuan
    NEURO-ONCOLOGY, 2020, 22 (09) : 1315 - 1326
  • [2] Upregulation of LY6K induced by FTO-mediated demethylation promotes the tumorigenesis and metastasis of oral squamous cell carcinoma via CAV-1-mediated ERK1/2 signaling activation
    Xu, Chen
    Gong, Rujuan
    Yang, Haibing
    HISTOLOGY AND HISTOPATHOLOGY, 2024, 39 (10) : 1359 - 1370
  • [3] Succinate promotes skeletal muscle protein synthesis via Erk1/2 signaling pathway(vol 16, pg 7361, 2017)
    Yuan, Yexian
    Xu, Yaqiong
    Xu, Jingren
    Liang, Bingqing
    Cai, Xingcai
    Zhu, Canjun
    Wang, Lina
    Wang, Songbo
    Zhu, Xiaotong
    Gao, Ping
    Wang, Xiuqi
    Zhang, Yongliang
    Jiang, Qingyan
    Shu, Gang
    MOLECULAR MEDICINE REPORTS, 2024, 30 (03)
  • [4] Interleukin-1β promotes interleulin-6 expression via ERK1/2 signaling pathway in canine dermal fibroblasts
    Kitanaka, Nanako
    Nakano, Rei
    Sugiura, Kanae
    Kitanaka, Taku
    Namba, Shinichi
    Konno, Tadayoshi
    Nakayama, Tomohiro
    Sugiya, Hiroshi
    PLOS ONE, 2019, 14 (07):
  • [5] RETRACTION: Berberine reduces temozolomide resistance by inducing autophagy via the ERK1/2 signaling pathway in glioblastoma (Retraction of Vol 20, art no 592, 2020)
    Qu, Huiling
    Song, Xiaofu
    Song, Zhuyin
    Jiang, Xin
    Gao, Xin
    Bai, Lijuan
    Wu, Jiao
    Na, Li
    Yao, Zhicheng
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [6] RETRACTION: HOTAIR Accelerates Dyskinesia in a MPTP-Lesioned Mouse Model of PD via SSTR1 Methylation-Mediated ERK1/2 Axis (Retraction of Vol 22, Pg 140, 2020)
    Cai, Lijun
    Tu, Li
    Yang, Xiulin
    Zhang, Qian
    Tian, Tian
    Gu, Rang
    Qu, Xiang
    Wang, Qian
    Tian, Jinyong
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2022, 28 : 531 - 531
  • [7] CCL8 secreted by tumor-associated macrophages promotes invasion and stemness of glioblastoma cells via ERK1/2 signaling
    Zhang, Xiang
    Chen, Lu
    Dang, Wei-qi
    Cao, Mian-fu
    Xiao, Jing-fang
    Lv, Sheng-qing
    Jiang, Wen-jie
    Yao, Xiao-hong
    Lu, Hui-min
    Miao, Jing-ya
    Wang, Yan
    Yu, Shi-cang
    Ping, Yi-fang
    Liu, Xin-dong
    Cui, You-hong
    Zhang, Xia
    Bian, Xiu-wu
    LABORATORY INVESTIGATION, 2020, 100 (04) : 619 - 629
  • [8] Pharmacological stimulation of sigma-1 receptor promotes activation of astrocyte via ERK1/2 and GSK3β signaling pathway (vol 392, pg 801, 2019)
    Wang, Yun
    Jiang, Hua-feng
    Ni, Jing
    Guo, Lin
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2022, 395 (01) : 119 - 120
  • [9] Thyroid Cancer-Associated Mitochondrial DNA Mutation G3842A Promotes Tumorigenicity via ROS-Mediated ERK1/2 Activation
    Chen, Sixi
    Bao, Xinzhu
    Chen, Hongzhi
    Jia, Manli
    Li, Wen
    Zhang, Luyi
    Fan, Runxiao
    Fang, Hezhi
    Jin, Liqin
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [10] Thyroid Cancer-Associated Mitochondrial DNA Mutation G3842A Promotes Tumorigenicity via ROS-Mediated ERK1/2 Activation
    Chen, Sixi
    Bao, Xinzhu
    Chen, Hongzhi
    Jia, Manli
    Li, Wen
    Zhang, Luyi
    Fan, Runxiao
    Fang, Hezhi
    Jin, Liqin
    Oxidative Medicine and Cellular Longevity, 2022, 2022
12345